Yes I know all of that Mer.
I also know, and have been invested in companies where unforeseen things have happened to the trial sites, which delayed the results from coming out on time.
So as an investor who understands the complexities involved in clinical trials, I’m always open for it to take a little longer than the “rough” timeframe that management usually gives out.
As I said in my previous comment, I’m not expecting this to be the case, however as an investor you should always be open to the possibility.
Ann: Imugene doses first patient in HER-Vaxx phase 2 trial, page-22
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
